← FDA Drug Approvals (Drugs@FDA)

GADOTERATE MEGLUMINE

ANDA · Abbreviated New Drug Application (Generic) · Sponsor: HAINAN POLY · Approved 2024-06-17

Drug application

FDA Application #

ANDA218073

Application type

Abbreviated New Drug Application (Generic)

Brand name

GADOTERATE MEGLUMINE

Generic name

GADOTERATE MEGLUMINE

Active ingredients

GADOTERATE MEGLUMINE

Dosage form

SOLUTION

Route

INTRAVENOUS

Marketing status

Prescription

Sponsor

HAINAN POLY

Manufacturer

Slate Run Pharmaceuticals, LLC

First approval

2024-06-17

Source

Authoritative

Drugs@FDA application overview

Machine

JSON-LD · Markdown